A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans

NCT02877173 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Arteriosclerosis Obliterans

Interventions

DRUG: Alprostadil Liposomes for Injection
DRUG: Alprostadil Injection

Sponsor

Guangzhou Yipinhong Pharmaceutical CO.,LTD